Herbal formula aims to stop bladder Cancer's return

NCT ID NCT07728474

Recruiting now Disease control Sponsor: LifeBiotic Medical Research Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This trial tests whether an oral herbal supplement called LCS103 can help prevent non-muscle invasive bladder cancer from recurring after surgery. Sixty adults who have had their bladder tumors completely removed will take either LCS103 plus standard care or standard care alone for one year. The study will track safety and how well the supplement works at keeping the cancer away.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an oral herbal formula called LCS103
What this could lead to: If it works, this could offer a simple, non-invasive way to reduce the risk of bladder cancer returning after surgery.
What could go wrong: This is an early-phase trial with only 60 participants, so results may not apply widely. The herbal formula may cause side effects or fail to prevent recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Contacts and locations

Locations

Rambam Health Care Campus, Urology Department
RECRUITING

Haifa, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.